Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
CONTEXT: Endogenous glucocorticoid excess (Cushing's syndrome) predominantly increases postprandial glucose concentration. The pattern of hyperglycemia induced by prednisolone has not been well characterized. OBJECTIVE: Our objective was to define the circadian effect of prednisolone on glucose concentration to optimize management of prednisolone-induced hyperglycemia. DESIGN AND SETTING: This was a cross-sectional study in a teaching hospital. PARTICIPANTS: Participants included 60 consecutive consenting subjects with chronic obstructive pulmonary disease admitted to hospital: 13 without known diabetes admitted for other indications and not treated with glucocorticoids (group 1), 40 without known diabetes admitted with an exacerbation of chronic obstructive pulmonary disease and treated with prednisolone (group 2, prednisolone = 30 ± 6 mg/d), and seven with known diabetes treated with prednisolone (group 3, prednisolone = 26 ± 9 mg/d). MAIN OUTCOME MEASURE: Interstitial glucose concentration was assessed during continuous glucose monitoring. RESULTS: Significantly more subjects in group 2 [21 of 40 (53%), P = 0.02] and group 3 [seven of seven (100%), P = 0.003] recorded a glucose of at least 200 mg/dl (≥11.1 mmol/liter) during continuous glucose monitoring than in group 1 [one of 13 (8%)]. The mean glucose concentration between 2400-1200 h for group 3 (142 ± 36 mg/dl) was significantly greater than in the other two groups (P < 0.005), whereas mean glucose concentrations between 2400-1200 h in group 1 (108 ± 16 mg/dl) and group 2 (112 ± 22 mg/dl) were not significantly different. In contrast, the mean glucose concentrations between 1200-2400 h for group 2 (142 ± 25 mg/dl) and group 3 (189 ± 32 mg/dl) were both significantly greater than group 1 (117 ± 14 mg/dl, P < 0.05 for both comparisons). CONCLUSIONS: Prednisolone predominantly causes hyperglycemia in the afternoon and evening. Treatment of prednisolone-induced hyperglycemia should be targeted at this time period.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rates of severe hypoglycemia events in ambulatory persons with end-stage kidney disease on dialysis are 10-fold higher than among other nondialysis persons with CKD and often associated with prolonged hypoglycemic episodes and poor response to regular hypoglycemia treatment.1375”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1375]
In the citing paper
“These findings are in line with previous reports of afternoon and evening hyperglycaemia under glucocorticoids in persons without DM.24 27 55”
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444 · cited 3×
“As such, currently, we would not support routine glucose lowering in patients with mild prednisolone-induced hyperglycemia but recommend individualized decision making based on the severity and duration of hyperglycemia, aiming to maintain blood glucose from 72–180 mg/dl (4–10 mmol/liter), in line with general recomme…”
BackgroundInfluentialDiagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · cited 1×
“However, endogenous glucocorticoid excess in Cushing’s syndrome predominantly increases postprandial blood glucose concentration with fasting glucose often in the normal range (8).”
BackgroundKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Weir, C. J., Murray, G. D., Dyker, A. G., & Lees, K. R. (1997) · BMJ · doi:10.1136/bmj.314.7090.1303 · Cited by 522 · cited 2×
“Hyperglycemic Effect of Glucocorticoids J Clin Endocrinol Metab, June 2011, 96(6):1789–1796”
BackgroundGlucocorticoid-induced hyperglycemia
Clore, J. N., & Thurby-Hay, L. (2009) · Endocrine Practice · doi:10.4158/ep08331.rar · Cited by 508
Deedwania, P., Kosiborod, M., Barrett, E., Ceriello, A., Isley, W., Mazzone, T., & Raskin, P. (2008) · Circulation · doi:10.1161/circulationaha.107.188629 · Cited by 488
Limitations of Conventional Methods of Self-Monitoring of Blood Glucose
Boland, E., Monsod, T., Delucia, M., Brandt, C. A., Fernando, S., & Tamborlane, W. V. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1858 · Cited by 423 · cited 1×
“CGMS provide detailed information regarding nocturnal and postprandial glycemia, whereas standard finger-prick blood glucose monitoring regimens do not (11).”
BackgroundBaker, E. H. (2006) · Thorax · doi:10.1136/thx.2005.051029 · Cited by 418
Cited by
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
“GCs also appear to have a greater impact on postprandial compared to fasting glucose levels [37].”
BackgroundCavaillès, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., Person-Tacnet, C., Leroyer, C., et al. (2013) · European Respiratory Review · doi:10.1183/09059180.00008612 · Cited by 510
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment
Hwang, J. L., & Weiss, R. E. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2486 · Cited by 380
“reported 12-year graft survival in diabetic patients to be 48% versus 70% in controls [33].”
BackgroundInfluentialProgress in the mechanism and targeted drug therapy for COPD
Wang, C., Zhou, J., Wang, J., Li, S., Fukunaga, A., Yodoi, J., & Tian, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00345-x · Cited by 303
Metadata
- Authors
- Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., Frith, P., & Stranks, S. N.
- Affiliations
- Flinders University (AU)
- Repatriation General Hospital (AU)
- Corresponding author
- Burt, Morton G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1789-1796
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2042010542
- Cited by
- 203
- References
- 22
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 10 · 2023: 14 · 2022: 12 · 2021: 16 · 2020: 25 · 2019: 14 · 2018: 17 · 2017: 10 · 2016: 13 · 2015: 9 · 2014: 13 · 2013: 18 · 2012: 8
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prednisolone, glucocorticoid-induced hyperglycemia, Cushing's syndrome, chronic obstructive pulmonary disease, COPD exacerbations, continuous glucose monitoring, interstitial glucose, postprandial hyperglycemia, diabetes mellitus, glucocorticoid adverse effects, timing of corticosteroid administration
- MeSH terms
- Aged, Aged, 80 and over, Anti-Inflammatory Agents, Blood Glucose, Cross-Sectional Studies, Female, Glycated Hemoglobin, Humans, Hyperglycemia, Male, Middle Aged, Prednisolone, Prospective Studies, Blood Glucose Self-Monitoring, Patient Selection, Postprandial Period, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. https://app.cochat.ai/papers/10.1210/jc.2010-2729
- The paper
- Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., Frith, P., & Stranks, S. N. (2011). Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-2729
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.